GlassScriptPhysician profile
Robert W Armbruster
NPI 1851373666
$7,303.83
in general payments reported to CMS, 2019-2025
36 companies · $576 in 2025
The $576 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,640 · 2020: $280 · 2021: $103 · 2022: $488 · 2023: $560 · 2024: $658 · 2025: $576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,793.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,660.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $455.85 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $439.11 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $320.97 | 2019-2023 | Repatha |
| Pfizer INC. | $241.36 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $221.05 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $217.41 | 2019-2024 | Lifevest |
| Boston Scientific Corporation | $160.80 | 2019-2025 | Watchman Flx, Watchman Access System, General - Atherectomy |
| Actelion Pharmaceuticals US, INC. | $157.53 | 2019-2024 | Uptravi, Opsumit |
| Angiodynamics, INC. | $152.74 | 2024 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $117.54 | 2022-2025 | Complete Se Vascular, Micra, Linq II |
| Itamar Medical INC | $102.45 | 2024-2025 | Watchpatone |
| Teleflex LLC | $98.90 | 2019-2025 | Trapliner, Guideliner |
| Scpharmaceuticals INC. | $90.18 | 2024 | |
| Shockwave Medical, INC | $87.45 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.81 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $76.43 | 2019-2025 | Farxiga |
| Gilead Sciences, INC. | $64.67 | 2019 | |
| Abiomed | $59.04 | 2019 | |
| Cardiva Medical, INC. | $58.67 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Cardiovascular Systems INC. | $56.04 | 2019-2020 | |
| Amarin Pharma, INC. | $49.86 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $44.06 | 2022-2024 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $41.77 | 2019 | |
| Medtronic Vascular, INC. | $36.28 | 2019 | |
| Lundbeck LLC | $28.98 | 2019 | |
| Esperion Therapeutics, INC. | $28.34 | 2022-2023 | Nexletol |
| Terumo Medical Corporation | $22.96 | 2021 | |
| Atricure, INC. | $22.04 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $19.46 | 2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $18.31 | 2022 | |
| Opsens INC. | $16.28 | 2021 | |
| Novo Nordisk INC | $15.75 | 2025 | Wegovy |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $15.59 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.47 | 2023 | |
| Irhythm Technologies, INC. | $13.68 | 2023 | Zio Xt Patch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Armbruster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.